Metabolic Syndrome: A Narrative Review from the Oxidative Stress to the Management of Related Diseases

被引:20
作者
Martemucci, Giovanni [1 ]
Fracchiolla, Giuseppe [2 ]
Muraglia, Marilena [2 ]
Tardugno, Roberta [2 ]
Dibenedetto, Roberta Savina [2 ]
D'Alessandro, Angela Gabriella [3 ]
机构
[1] Univ Bari Aldo Moro, Dept Agr & Environm Sci, I-70126 Bari, Italy
[2] Univ Bari Aldo Moro, Dept Pharm Drug Sci, I-70126 Bari, Italy
[3] Univ Bari Aldo Moro, Dept Soil Plant & Food Sci, I-70126 Bari, Italy
关键词
metabolic syndrome; diabesity; gut microbiota; dysbiosis; cardiovascular diseases; neurodegeneration; LOW-DENSITY-LIPOPROTEIN; GLYCATION END-PRODUCTS; BODY-MASS INDEX; GUT MICROBIOTA COMPOSITION; SUGAR-SWEETENED BEVERAGES; TYPE-2; DIABETES-MELLITUS; BILE-ACID METABOLISM; FATTY LIVER-DISEASE; C-REACTIVE PROTEIN; ADIPOSE-TISSUE INFLAMMATION;
D O I
10.3390/antiox12122091
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Metabolic syndrome (MS) is a growing disorder affecting thousands of people worldwide, especially in industrialised countries, increasing mortality. Oxidative stress, hyperglycaemia, insulin resistance, inflammation, dysbiosis, abdominal obesity, atherogenic dyslipidaemia and hypertension are important factors linked to MS clusters of different pathologies, such as diabesity, cardiovascular diseases and neurological disorders. All biochemical changes observed in MS, such as dysregulation in the glucose and lipid metabolism, immune response, endothelial cell function and intestinal microbiota, promote pathological bridges between metabolic syndrome, diabesity and cardiovascular and neurodegenerative disorders. This review aims to summarise metabolic syndrome's involvement in diabesity and highlight the link between MS and cardiovascular and neurological diseases. A better understanding of MS could promote a novel strategic approach to reduce MS comorbidities.
引用
收藏
页数:46
相关论文
共 609 条
[61]   Apelin, a newly identified adipokine up-regulated by insulin and obesity [J].
Boucher, J ;
Masri, B ;
Daviaud, D ;
Gesta, S ;
Guigné, C ;
Mazzucotelli, A ;
Castan-Laurell, I ;
Tack, I ;
Knibiehler, B ;
Carpéné, C ;
Audigier, Y ;
Saulnier-Blache, JS ;
Valet, P .
ENDOCRINOLOGY, 2005, 146 (04) :1764-1771
[62]   NIH working group report-using genomic information to guide weight management: From universal to precision treatment [J].
Bray, Molly S. ;
Loos, Ruth J. F. ;
McCaffery, Jeanne M. ;
Ling, Charlotte ;
Franks, Paul W. ;
Weinstock, George M. ;
Snyder, Michael P. ;
Vassy, Jason L. ;
Agurs-Collins, Tanya .
OBESITY, 2016, 24 (01) :14-22
[63]   Commensal bacteria at the interface of host metabolism and the immune system [J].
Brestoff, Jonathan R. ;
Artis, David .
NATURE IMMUNOLOGY, 2013, 14 (07) :676-684
[64]   Biochemistry and molecular cell biology of diabetic complications [J].
Brownlee, M .
NATURE, 2001, 414 (6865) :813-820
[65]   The pathobiology of diabetic complications - A unifying mechanism [J].
Brownlee, M .
DIABETES, 2005, 54 (06) :1615-1625
[66]   Endothelial dysfunction in cardiovascular diseases - The role of oxidant stress [J].
Cai, H ;
Harrison, DG .
CIRCULATION RESEARCH, 2000, 87 (10) :840-844
[67]   Oral glycotoxins determine the effects of calorie restriction on oxidant stress, age-related diseases, and lifespan [J].
Cai, Weijing ;
He, John C. ;
Zhu, Li ;
Chen, Xue ;
Zheng, Feng ;
Striker, Gary E. ;
Vlassara, Helen .
AMERICAN JOURNAL OF PATHOLOGY, 2008, 173 (02) :327-336
[68]   Sugar- and Artificially Sweetened Beverages and Intrahepatic Fat: A Randomized Controlled Trial [J].
Campos, Vanessa ;
Despland, Camille ;
Brandejsky, Vaclav ;
Kreis, Roland ;
Schneiter, Philippe ;
Chiolero, Arnaud ;
Boesch, Chris ;
Tappy, Luc .
OBESITY, 2015, 23 (12) :2335-2339
[69]   Impact of dietary fat on gut microbiota and low-grade systemic inflammation: mechanisms and clinical implications on obesity [J].
Candido, Flavia Galvao ;
Valente, Flavia Xavier ;
Grzeskowiak, Lukasz Marcin ;
Boroni Moreira, Ana Paula ;
Usuda Prado Rocha, Daniela Mayumi ;
Goncalves Alfenas, Rita de Cassia .
INTERNATIONAL JOURNAL OF FOOD SCIENCES AND NUTRITION, 2018, 69 (02) :125-143
[70]   Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability [J].
Cani, P. D. ;
Possemiers, S. ;
Van de Wiele, T. ;
Guiot, Y. ;
Everard, A. ;
Rottier, O. ;
Geurts, L. ;
Naslain, D. ;
Neyrinck, A. ;
Lambert, D. M. ;
Muccioli, G. G. ;
Delzenne, N. M. .
GUT, 2009, 58 (08) :1091-1103